Multi-site study demonstrates efficacy of Draxxin® for SRD
Dec 21, 2021Jennifer Grullon
DISCOVERIES, Issue 11: A multi-site study of pigs with swine respiratory disease (SRD) demonstrates that one dose of Draxxin® (tulathromycin) not only lowers mortality, it can significantly improve...
One dose of Draxxin® at weaning for SRD yields multiple benefit
Oct 01, 2021Jennifer Grullon
DISCOVERIES, Issue 13: Pigs from herds with a natural outbreak of swine respiratory disease (SRD) had significantly better outcomes when they received just one injection of Draxxin® (tulathromycin)...
Antimicrobial’s unique attributes explain efficacy against key SRD pathogens
Sep 15, 2021Jennifer Grullon
DISCOVERIES, Issue 12: The efficacy of Draxxin® (tulathromycin) against key swine respiratory disease (SRD) pathogens is largely due to the antimicrobial’s ability to reach and sustain high...
Pharmacology explains efficacy of Draxxin® for SRD
Aug 04, 2021Jennifer Grullon
DISCOVERIES, Issue 27: Pharmacologic research demonstrating how Draxxin® (tulathromycin) injection behaves in the pig explains why this antimicrobial remains a valuable treatment for swine...
SRD pathogens remain highly susceptible to key antimicrobials
Jun 24, 2021Jennifer Grullon
DISCOVERIES, Issue 25: Pathogens commonly associated with swine respiratory disease (SRD) remain highly susceptible to key veterinary antimicrobials,
Long duration of antibiotic helps improve clinical outcome after APP challenge
Jun 15, 2021Jennifer Grullon
DISCOVERIES, Issue 10: Pigs treated with one intramuscular dose of Draxxin® (tulathromycin) and then challenged with a virulent strain of APP had significantly reduced mortality and lung lesions...
M. hyo treatment with Draxxin® plays important role in SRD management
Mar 02, 2019Jennifer Grullon
DISCOVERIES, Issue 14: Pigs treated for Mycoplasma hyopneumoniae (M. hyo) with a single dose of the injectable antimicrobial Draxxin® (tulathromycin) had significantly better average daily gain and...
